Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers.
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), is a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) is a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today the …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) successfully completed foundational phases of development of an antibody construct labeled with actinium-225 using the Company’s novel proprietary APIT …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it entered …
I’m always hunting for small-cap biotech stocks with under-appreciated drug pipelines or technology that target high unmet medical needs. Sure, I also …